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Background
Persistent gliosis, if present in shunt-dependent hydro-
cephalus, has the potential to alter the biomechanical
properties of the brain, impair cerebral perfusion, and
impede neuronal regeneration and plasticity. Determin-
ing the onset, progression, and reversibility of gliosis due
to hydrocephalus is important in designing and imple-
menting better clinical treatments for this disorder. Thus,
gliosis was studied as the severity of hydrocephalus
increased in five, twelve and twenty one day old untreated
H-Tx rats with congenital hydrocephalus and control lit-
termates. Previous clinical and experimental studies have
suggested that gliosis may persist after shunting, but these
findings have been based on relatively short post-shunt
survival times.
Materials and methods
In an effort to determine the effects of post-shunt recovery
time on hydrocephalus-induced gliosis, we placed neona-
tal low-pressure ventriculo-subcutaneous shunts in 15 day
old H-Tx rats with severe hydrocephalus, and sacrificed
these animals 1 or 3 weeks later. Tissue from different
regions of the cerebral cortex was processed for routine
immunohistochemistry and Western blot procedures, and
probed for both microglial (Isolectin B4, ILB4) and astro-
cytic (Glial Fibrillary Acidic Protein, GFAP) proteins.
Results
Western blot analysis revealed a marked increase in GFAP
protein in both the occipital and parietal cortices of 12
day old hydrocephalic animals, suggesting that an
increase in pressure was the trigger for the onset of gliosis.
The dramatic rise in GFAP expression continued to be
seen in both 21- and 36-day old untreated hydrocephalic
animals as well. Shunting these hydrocephalic animals in
order to reduce the increased intracranial pressure had a
significant effect; both short and long recovery periods
were able to reduce the amount of gliosis present, indicat-
ing that shunting is an effective treatment for reversing
persistent gliosis. Immunohistochemical examination of
GFAP followed similar up-regulation trends as seen in the
Western blot analysis.
ILB4 blots indicated that in young hydrocephalic animals
(5 & 12 day animals) there was a trend toward up-regula-
tion of microglia in response to hydrocephalus, but from
day 21 and beyond, microglia levels decreased in response
to injury. Shunted hydrocephalic animals exhibited
microglia levels similar to those of control animals. On
histochemical examinations, microglia appeared to be
developmentally delayed in young hydrocephalic ani-
mals, and in the older 21 and 36 day hydrocephalic ani-
mals, they exhibited an activated morphology.
Morphologically, microglia in shunted animals appear to
be in a state of recovery; i.e. they are not as activated as in
hydrocephalic animals, but still show some signs of reac-
tivity.
Conclusion
Overall, these results suggest that reactive astrocytosis and
microgliosis are associated with progressive untreated
ventriculomegaly, but that appropriately timed shunting
can reverse most of these effects. It remains to be seen,
however, if gliosis behaves the same with persistent shunt
malfunctions.
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